Oxford to Study Anti-inflammatory Drug Humira as Potential COVID-19 Treatment Oxford to Study Anti-inflammatory Drug Humira as Potential COVID-19 Treatment

Oxford University said on Wednesday it would study whether the world ' s best-selling prescription medicine, adalimumab, was an effective treatment for COVID-19 patients.Reuters Health Information
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Infectious Diseases News Source Type: news